Data Bridge Market Research analyses that the multiplex molecular diagnosis technology market which was USD 37.04 billion in 2021, would rocket up to USD 76.00 billion by 2029, and is expected to undergo a CAGR of 9.40% during the forecast period 2022 to 2029.